Overview of Cardiac Arrhythmias and Treatment Strategies

Area of Science:

• Cardiovascular Physiology
• Cardiac Electrophysiology
• Medical Genetics

Background:

• Normal cardiac rhythm depends on coordinated ion channel and transporter function for electrical impulse propagation.
• Disruptions in this process lead to cardiac arrhythmias, which can be life-threatening.
• Structural heart disease (e.g., myocardial infarction, left ventricular dysfunction) and genetic polymorphisms increase arrhythmia risk.

Purpose of the Study:

• To provide an overview of the pathophysiology of inherited and acquired cardiac arrhythmias.
• To summarize current pharmacologic and non-pharmacologic treatments for cardiac arrhythmias.
• To highlight the challenges in identifying arrhythmia triggers and the need for further research.

Main Methods:

• Review of existing knowledge on the physiopathology of cardiac arrhythmias.
• Summary of therapeutic strategies for managing cardiac arrhythmias.
• Discussion of genetic influences and their impact on arrhythmia susceptibility and drug metabolism.

Main Results:

• Cardiac arrhythmias result from disruptions in normal myocardial electrical activity.
• Both inherited and acquired factors, including structural heart disease and genetic polymorphisms, contribute to arrhythmia development.
• Genetic variations in drug-metabolizing enzymes create distinct population subgroups affecting drug efficacy.

Conclusions:

• Understanding the molecular and cellular basis of arrhythmogenesis is crucial for developing novel treatments.
• Epidemiologic studies are needed to accurately determine the incidence and prevalence of cardiac arrhythmias.
• Improved knowledge is essential for effective management of cardiac arrhythmias and their associated morbidity and mortality, given their increasing global incidence.